Argus Research Initiates Coverage On 10x Genomics with Buy Rating, Announces Price Target of $110

Argus Research has initiated coverage on 10x Genomics (NASDAQ: TXG) with a Buy rating. The firm has set a price target of $110 for the company's stock.